Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks.Delivers up to 2x increase in resolving power and sensitivity to identify and track low-level impurities for improved regulatory readiness.Industry-first chemical and physical particle optimization delivers reproducible methods for increasingly complex biologics.MILFORD, Mass., June 8, 2026 /PRNewswire/ -- 55th International Symposium on High